SIRT1 and type 2 diabetes mellitus: In other studies, Oza assessed the SIRT1 stimulatory properties of FMNT to kidney damage and neuropathy in type 2 diabetes rats, and spotted that the low expression of SIRT1 was observably reversed after administration with FMNT for 16 weeks (Oza and Kulkarni, 2019; 2020).